Skip to main content
PMC home page
Applied and Environmental Microbiology logoLink to Applied and Environmental Microbiology
. 1995 Nov;61(11):3894–3903. doi: 10.1128/aem.61.11.3894-3903.1995

Isolation and characterization of genetically engineered gallidermin and epidermin analogs.

B Ottenwälder 1, T Kupke 1, S Brecht 1, V Gnau 1, J Metzger 1, G Jung 1, F Götz 1
PMCID: PMC167695  PMID: 8526502

Abstract

Gallidermin (Gdm) and epidermin (Epi) are highly homologous tetracyclic polypeptide antibiotics that are ribosomally synthesized by a Staphylococcus gallinarum strain and a Staphylococcus epidermidis strain, respectively. These antibiotics are secreted into media and are distinguished by the presence of the unusual amino acids lanthionine, 3-methyllanthionine, didehydrobutyrine, and S-(2-aminovinyl)-D-cysteine, which are formed by posttranslational modification. To study the substrate specificities of the modifying enzymes and to obtain variants that exhibit altered or new biological activities, we changed certain amino acids by performing site-specific mutagenesis with the Gdm and Epi structural genes (gdmA and epiA, respectively). S. epidermidis Tü3298/EMS6, an epiA mutant of the Epi-producing strain, was used as the expression host. This mutant synthesized Epi, Gdm, or analogs of these antibiotics when the appropriate genes were introduced on a plasmid. No Epi or Gdm analogs were isolated from the supernatant when (i) hydroxyamino acids involved in thioether amino acid formation were replaced by nonhydroxyamino acids (S3N and S19A); (ii) C residues involved in thioether bridging were deleted (delta C21, C22 and delta C22); or (iii) a ring amino acid was replaced by an amino acid having a completely different character (G10E and Y20G). A strong decrease in production was observed when S residues involved in thioether amino acid formation were replaced by T residues (S16T and S19T). A number of conservative changes at positions 6, 12, and 14 on the Gdm backbone were tolerated and led to analogs that had altered biological properties, such as enhanced antimicrobial activity (L6V) or a remarkable resistance to proteolytic degradation (A12L and Dhb14P). The T14S substitution led to simultaneous production of two Gdm species formed by incomplete posttranslational modification (dehydration) of the S-14 residue. The fully modified Dhb14Dha analog exhibited antimicrobial activity similar to that of Gdm, whereas the Dhb14S analog was less active. Both peptides were more sensitive to tryptic cleavage than Gdm was.

Full Text

The Full Text of this article is available as a PDF (466.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allgaier H., Jung G., Werner R. G., Schneider U., Zähner H. Epidermin: sequencing of a heterodetic tetracyclic 21-peptide amide antibiotic. Eur J Biochem. 1986 Oct 1;160(1):9–22. doi: 10.1111/j.1432-1033.1986.tb09933.x. [DOI] [PubMed] [Google Scholar]
  2. Augustin J., Götz F. Transformation of Staphylococcus epidermidis and other staphylococcal species with plasmid DNA by electroporation. FEMS Microbiol Lett. 1990 Jan 1;54(1-3):203–207. doi: 10.1016/0378-1097(90)90283-v. [DOI] [PubMed] [Google Scholar]
  3. Augustin J., Rosenstein R., Wieland B., Schneider U., Schnell N., Engelke G., Entian K. D., Götz F. Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis. Eur J Biochem. 1992 Mar 15;204(3):1149–1154. doi: 10.1111/j.1432-1033.1992.tb16740.x. [DOI] [PubMed] [Google Scholar]
  4. Bierbaum G., Reis M., Szekat C., Sahl H. G. Construction of an expression system for engineering of the lantibiotic Pep5. Appl Environ Microbiol. 1994 Dec;60(12):4332–4338. doi: 10.1128/aem.60.12.4332-4338.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bierbaum G., Sahl H. G. Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase. J Bacteriol. 1987 Dec;169(12):5452–5458. doi: 10.1128/jb.169.12.5452-5458.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bierbaum G., Sahl H. G. Lantibiotics--unusually modified bacteriocin-like peptides from gram-positive bacteria. Zentralbl Bakteriol. 1993 Feb;278(1):1–22. doi: 10.1016/s0934-8840(11)80275-6. [DOI] [PubMed] [Google Scholar]
  7. Birnboim H. C., Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 1979 Nov 24;7(6):1513–1523. doi: 10.1093/nar/7.6.1513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chen E. Y., Seeburg P. H. Supercoil sequencing: a fast and simple method for sequencing plasmid DNA. DNA. 1985 Apr;4(2):165–170. doi: 10.1089/dna.1985.4.165. [DOI] [PubMed] [Google Scholar]
  9. Freund S., Jung G., Gutbrod O., Folkers G., Gibbons W. A., Allgaier H., Werner R. The solution structure of the lantibiotic gallidermin. Biopolymers. 1991 May;31(6):803–811. doi: 10.1002/bip.360310626. [DOI] [PubMed] [Google Scholar]
  10. Gross E., Kiltz H. H., Nebelin E. Subtilin, VI. Die Struktur des Subtilins. Hoppe Seylers Z Physiol Chem. 1973 Jul;354(7):810–812. [PubMed] [Google Scholar]
  11. Gross E., Morell J. L. The structure of nisin. J Am Chem Soc. 1971 Sep 8;93(18):4634–4635. doi: 10.1021/ja00747a073. [DOI] [PubMed] [Google Scholar]
  12. Jack R., Benz R., Tagg J., Sahl H. G. The mode of action of SA-FF22, a lantibiotic isolated from Streptococcus pyogenes strain FF22. Eur J Biochem. 1994 Jan 15;219(1-2):699–705. doi: 10.1111/j.1432-1033.1994.tb19986.x. [DOI] [PubMed] [Google Scholar]
  13. Kellner R., Jung G., Hörner T., Zähner H., Schnell N., Entian K. D., Götz F. Gallidermin: a new lanthionine-containing polypeptide antibiotic. Eur J Biochem. 1988 Oct 15;177(1):53–59. doi: 10.1111/j.1432-1033.1988.tb14344.x. [DOI] [PubMed] [Google Scholar]
  14. Kordel M., Schüller F., Sahl H. G. Interaction of the pore forming-peptide antibiotics Pep 5, nisin and subtilin with non-energized liposomes. FEBS Lett. 1989 Feb 13;244(1):99–102. doi: 10.1016/0014-5793(89)81171-8. [DOI] [PubMed] [Google Scholar]
  15. Kramer W., Fritz H. J. Oligonucleotide-directed construction of mutations via gapped duplex DNA. Methods Enzymol. 1987;154:350–367. doi: 10.1016/0076-6879(87)54084-8. [DOI] [PubMed] [Google Scholar]
  16. Kuipers O. P., Rollema H. S., Yap W. M., Boot H. J., Siezen R. J., de Vos W. M. Engineering dehydrated amino acid residues in the antimicrobial peptide nisin. J Biol Chem. 1992 Dec 5;267(34):24340–24346. [PubMed] [Google Scholar]
  17. Kupke T., Kempter C., Gnau V., Jung G., Götz F. Mass spectroscopic analysis of a novel enzymatic reaction. Oxidative decarboxylation of the lantibiotic precursor peptide EpiA catalyzed by the flavoprotein EpiD. J Biol Chem. 1994 Feb 25;269(8):5653–5659. [PubMed] [Google Scholar]
  18. Kupke T., Kempter C., Jung G., Götz F. Oxidative decarboxylation of peptides catalyzed by flavoprotein EpiD. Determination of substrate specificity using peptide libraries and neutral loss mass spectrometry. J Biol Chem. 1995 May 12;270(19):11282–11289. doi: 10.1074/jbc.270.19.11282. [DOI] [PubMed] [Google Scholar]
  19. Kupke T., Stevanović S., Sahl H. G., Götz F. Purification and characterization of EpiD, a flavoprotein involved in the biosynthesis of the lantibiotic epidermin. J Bacteriol. 1992 Aug;174(16):5354–5361. doi: 10.1128/jb.174.16.5354-5361.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Liu W., Hansen J. N. Enhancement of the chemical and antimicrobial properties of subtilin by site-directed mutagenesis. J Biol Chem. 1992 Dec 15;267(35):25078–25085. [PubMed] [Google Scholar]
  21. Liu W., Hansen J. N. The antimicrobial effect of a structural variant of subtilin against outgrowing Bacillus cereus T spores and vegetative cells occurs by different mechanisms. Appl Environ Microbiol. 1993 Feb;59(2):648–651. doi: 10.1128/aem.59.2.648-651.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Meyer H. E., Heber M., Eisermann B., Korte H., Metzger J. W., Jung G. Sequence analysis of lantibiotics: chemical derivatization procedures allow a fast access to complete Edman degradation. Anal Biochem. 1994 Dec;223(2):185–190. doi: 10.1006/abio.1994.1571. [DOI] [PubMed] [Google Scholar]
  23. Peschel A., Augustin J., Kupke T., Stevanovic S., Götz F. Regulation of epidermin biosynthetic genes by EpiQ. Mol Microbiol. 1993 Jul;9(1):31–39. doi: 10.1111/j.1365-2958.1993.tb01666.x. [DOI] [PubMed] [Google Scholar]
  24. Reisinger P., Seidel H., Tschesche H., Hammes W. P. The effect of nisin on murein synthesis. Arch Microbiol. 1980 Oct;127(3):187–193. doi: 10.1007/BF00427192. [DOI] [PubMed] [Google Scholar]
  25. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Schnell N., Engelke G., Augustin J., Rosenstein R., Ungermann V., Götz F., Entian K. D. Analysis of genes involved in the biosynthesis of lantibiotic epidermin. Eur J Biochem. 1992 Feb 15;204(1):57–68. doi: 10.1111/j.1432-1033.1992.tb16605.x. [DOI] [PubMed] [Google Scholar]
  27. Schnell N., Entian K. D., Götz F., Hörner T., Kellner R., Jung G. Structural gene isolation and prepeptide sequence of gallidermin, a new lanthionine containing antibiotic. FEMS Microbiol Lett. 1989 Apr;49(2-3):263–267. doi: 10.1016/0378-1097(89)90050-5. [DOI] [PubMed] [Google Scholar]
  28. Schnell N., Entian K. D., Schneider U., Götz F., Zähner H., Kellner R., Jung G. Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings. Nature. 1988 May 19;333(6170):276–278. doi: 10.1038/333276a0. [DOI] [PubMed] [Google Scholar]
  29. Vogel H., Nilsson L., Rigler R., Meder S., Boheim G., Beck W., Kurth H. H., Jung G. Structural fluctuations between two conformational states of a transmembrane helical peptide are related to its channel-forming properties in planar lipid membranes. Eur J Biochem. 1993 Mar 1;212(2):305–313. doi: 10.1111/j.1432-1033.1993.tb17663.x. [DOI] [PubMed] [Google Scholar]
  30. Weil H. P., Beck-Sickinger A. G., Metzger J., Stevanovic S., Jung G., Josten M., Sahl H. G. Biosynthesis of the lantibiotic Pep5. Isolation and characterization of a prepeptide containing dehydroamino acids. Eur J Biochem. 1990 Nov 26;194(1):217–223. doi: 10.1111/j.1432-1033.1990.tb19446.x. [DOI] [PubMed] [Google Scholar]
  31. Wieland B., Feil C., Gloria-Maercker E., Thumm G., Lechner M., Bravo J. M., Poralla K., Götz F. Genetic and biochemical analyses of the biosynthesis of the yellow carotenoid 4,4'-diaponeurosporene of Staphylococcus aureus. J Bacteriol. 1994 Dec;176(24):7719–7726. doi: 10.1128/jb.176.24.7719-7726.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Zell R., Fritz H. J. DNA mismatch-repair in Escherichia coli counteracting the hydrolytic deamination of 5-methyl-cytosine residues. EMBO J. 1987 Jun;6(6):1809–1815. doi: 10.1002/j.1460-2075.1987.tb02435.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Applied and Environmental Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES